CHU Tours

Running trials

• Not yet recruiting

  Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer

  NCT07828938· Source

• Not yet recruiting

  Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

  NCT07437287· Phase 2/3· Source

• Recruiting

  Cohort of Patients With Chronic Myelomonocytic Leukemia

  NCT07512882· Source

• Recruiting

  Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)

  NCT07317102· Source

• Recruiting

  The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

  NCT07211126· Source

• Recruiting

  Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke

  NCT07065929· Source

• Recruiting

  Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis

  NCT06549231· Phase 3· Source

• Recruiting

  Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients

  NCT06481813· Source

• Recruiting

  Identification of Early Markers for ALS

  NCT07213440· Source

• Recruiting

  Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.

  NCT05440838· Source

• Recruiting

  Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment

  NCT05580861· Phase 1/2· Source

• Recruiting

  Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study

  NCT04935853· Source

• Active, not recruiting

  Observatory of Patients With Haemophilia B Treated by IdElvion®

  NCT05086575· Source

• Recruiting

  Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

  NCT04942080· Source

• Recruiting

  Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

  NCT04927156· Source

• Recruiting

  Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

  NCT04802135· Source

• Recruiting

  LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients

  NCT04768322· Source

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT04477681· Source

• Active, not recruiting

  Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)

  NCT04602091· Source

• Active, not recruiting

  Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)

  NCT02767063· Phase 1/2· Source

• Enrolling by invitation

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Source

• Active, not recruiting

  Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

  NCT02870907· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer2 recruiting
• Lung cancer2 recruiting
• Myeloproliferative neoplasms2 recruiting
• Stroke2 recruiting
• Type 1 diabetes2 recruiting
• Acute myeloid leukemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Childhood cancers1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Epilepsy1 recruiting
• Heart failure1 recruiting
• Rheumatoid arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

  NCT04590144· Source

• Recruiting

  Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

  NCT04356326· Phase 3· Source

• Terminated

  Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.

  NCT03312075· Source

• Completed

  Evaluation of the Impact of Multiple Sclerosis and Its Treatments on Women Fertility

  NCT07164924· Source